BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12661751)

  • 1. Onycholysis associated with paclitaxel.
    Mackay-Wiggan J; Nair KG; Halasz CL
    Cutis; 2003 Mar; 71(3):229-32. PubMed ID: 12661751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onycholysis associated with weekly administration of paclitaxel.
    Flory SM; Solimando DA; Webster GF; Dunton CJ; Neufeld JM; Haffey MB
    Ann Pharmacother; 1999 May; 33(5):584-6. PubMed ID: 10369623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nail toxicity related to taxanes.
    Mourad YA; Matta-Muallem M; Shamseddine A
    Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].
    Freites-Martínez A; Martinez-Sánchez D; de Pablo NP; Calderón-Komaromy A; Córdoba S; Burbujo J
    Invest Clin; 2014 Mar; 55(1):55-60. PubMed ID: 24758102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 6. Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer.
    Cohen PR
    J Drugs Dermatol; 2009 Jan; 8(1):61-4. PubMed ID: 19180897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nail alterations secondary to pactitaxel [corrected] therapy.
    Almagro M; Pozo JD; Garcia J; Vasquez A; Fonseca E
    Eur J Dermatol; 2000 Mar; 10(2):146-7. PubMed ID: 10694317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature.
    Hussain S; Anderson DN; Salvatti ME; Adamson B; McManus M; Braverman AS
    Cancer; 2000 May; 88(10):2367-71. PubMed ID: 10820360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subungal abcesses secondary to paclitaxel.
    Albares MP; Belinchón I; Pascual JC; Vergara G; Blanes M; Betlloch I
    Dermatol Online J; 2003 Aug; 9(3):16. PubMed ID: 12952763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Yellow nails].
    Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
    Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
    Hesketh PJ; Crowley JJ; Burris HA; Williamson SK; Balcerzak SP; Peereboom D; Goodwin JW; Gross HM; Moore DF; Livingston RB; Gandara DR
    Cancer J Sci Am; 1999; 5(4):237-41. PubMed ID: 10439170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
    Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
    Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of paclitaxel in patients with alcohol abuse histories.
    Henderson-Martin B
    Clin J Oncol Nurs; 2000; 4(1):11-4. PubMed ID: 10865578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel is effective in the treatment of metastatic endometrial cancer.
    Günthert AR; Pilz S; Kuhn W; Emons G; Meden H
    Anticancer Res; 1999; 19(4C):3459-61. PubMed ID: 10629635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
    Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel extravasation causing significant delayed tissue injury.
    Raley J; Geisler JP; Buekers TE; Sorosky JI
    Gynecol Oncol; 2000 Aug; 78(2):259-60. PubMed ID: 10926814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe interstitial pneumonia induced by paclitaxel in a patient with adenocarcinoma of the lung.
    Suzaki N; Hiraki A; Takigawa N; Ueoka H; Tanimoto Y; Kozuki T; Tabata M; Kanehiro A; Kiura K; Tanimoto M
    Acta Med Okayama; 2006 Oct; 60(5):295-8. PubMed ID: 17072376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel-induced acral erythema and nail changes distributed to photoexposed areas.
    Ferreira O; Baudrier T; Mota A; Duarte AF; Azevedo F
    Cutan Ocul Toxicol; 2010 Dec; 29(4):296-9. PubMed ID: 20608863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
    Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
    Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe dermatologic reactions at multiple sites after paclitaxel administration.
    Beri R; Rosen FR; Pacini MJ; Desai SR
    Ann Pharmacother; 2004 Feb; 38(2):238-41. PubMed ID: 14742758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.